ArticleOpen forum infectious diseases2018

Durability of Efavirenz Compared With Boosted Protease Inhibitor-Based Regimens in Antiretroviral-Naïve Patients in the Caribbean and Central and South America.

Yanink Caro-Vega et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.